Does EVOLOCUMAB Cause Occupational exposure to product? 950 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 950 reports of Occupational exposure to product have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.6% of all adverse event reports for EVOLOCUMAB.
950
Reports of Occupational exposure to product with EVOLOCUMAB
0.6%
of all EVOLOCUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Occupational exposure to product From EVOLOCUMAB?
Of the 950 reports.
Is Occupational exposure to product Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 950 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Occupational exposure to product?
PEGFILGRASTIM (1,407)
ERENUMAB-AOOE (711)
DENOSUMAB (552)
LEUPROLIDE (326)
ETANERCEPT (202)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (97)
MENTHOL\ZINC (81)
BLINATUMOMAB (65)
ENOXAPARIN (60)
CARFILZOMIB (48)
Which EVOLOCUMAB Alternatives Have Lower Occupational exposure to product Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE